Nuventra Pharma Sciences is now Allucent. Learn more here.

Take a deeper dive

Webinar | Drug Development Considerations for Dermatology:
More Than Skin Deep

This webinar covers an introduction to topical drug development and other important clinical pharmacology considerations for products for dermatological conditions. Topically applied drugs often follow different requirements for pharmacokinetic (PK) assessment than drugs administered orally or intravenously. During the webinar, issues specific for topical drug development will be discussed including various requirements, such as the maximal usage trial (MuST) for a successful application.

At the end of this webinar attendees should have a better understanding of:

  • Why does formulation matter?
  • How to collect and interpret pharmacokinetics for topically applied products
  • Regulatory requirements and clinical pharmacology considerations

Meet the Speaker

Elizabeth (Betty) Hussey, Pharm.D.
Vice President, Clinical Pharmacology & Pharmacokinetics

Dr. Hussey has over 30 years of extensive leadership and experience in drug development, clinical development, clinical pharmacology, and pharmacokinetics across multiple therapeutic areas and all phases of development. Dr. Hussey’s primary therapeutic area experience includes dermatology, metabolic diseases, CNS (headaches), antivirals, and anti-infectives with focus on early proof-of-concept.

Explore Our Blog

Personalized & Precision Medicine in Drug Development

The importance of individual patients has long been recognized by the medical industry. There is an old saying that helps…

Read More

Developing Oligonucleotide Therapies

Oligonucleotides are short strands of DNA or RNA molecules that contain a small number of nucleotides. Each nucleotide consists of…

Read More

Common Clinical Pharmacology Mistakes to Avoid in Drug Development

Drug development is a complex process where clinical pharmacology data must be generated to support regulatory approval and marketing authorization.…

Read More